about
Spectrum of Viral Pathogens in Blood of Malaria-Free Ill Travelers Returning to CanadaGenetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplicationLong term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipientsHumoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccinationSeroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010Evaluation of Altona Diagnostics RealStar Zika Virus RT-PCR Test Kit for Zika virus PCR testingEvaluation of Euroimmun Anti-Zika Virus IgM and IgG Enzyme-Linked Immunosorbent Assays for Zika Virus Serologic Testing.Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.Low seroconversion after one dose of AS03-adjuvanted H1N1 pandemic influenza vaccine in solid-organ transplant recipientsPreexisting CD4+ T-cell immunity in human population to avian influenza H7N9 virus: whole proteome-wide immunoinformatics analyses.Multiplex PCR tests sentinel the appearance of pandemic influenza viruses including H1N1 swine influenza.Respiratory infection in institutions during early stages of pandemic (H1N1) 2009, Canada.Transmission of influenza A pandemic (H1N1) 2009 virus in a long-term care facility in Ontario, Canada.Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment.Early post-transplant vaccination with pandemic influenza A/H1N1 vaccine in pediatric heart transplant recipients.Neuraminidase-inhibitor resistance testing for pandemic influenza A (H1N1) 2009 in Ontario, Canada.Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.When should a diagnosis of influenza be considered in adults requiring intensive care unit admission? Results of population-based active surveillance in TorontoMultidrug-resistant pandemic (H1N1) 2009 infection in immunocompetent childRespiratory viral infections in institutions from late stage of the first and second waves of pandemic influenza A (H1N1) 2009, Ontario, Canada.Community-acquired respiratory viruses and co-infection among patients of Ontario sentinel practices, April 2009 to February 2010.Expression of recombinant HA1 protein for specific detection of influenza A/H1N1/2009 antibodies in human serum.Evaluation of 2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies receiving chemotherapy or following autologous stem cell transplant.Risk factors for influenza among health care workers during 2009 pandemic, Toronto, Ontario, CanadaT cell memory to evolutionarily conserved and shared hemagglutinin epitopes of H1N1 viruses: a pilot scale study.Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing.Measles Outbreak with Unique Virus Genotyping, Ontario, Canada, 2015.Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites.Multiple influenza A (H3N2) mutations conferring resistance to neuraminidase inhibitors in a bone marrow transplant recipient.Local public health response to vaccine-associated measles: case report.Performance of rapid influenza diagnostic testing in outbreak settings.An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada.Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating virusesEvaluation and verification of the Seeplex Diarrhea-V ACE assay for simultaneous detection of adenovirus, rotavirus, and norovirus genogroups I and II in clinical stool specimens.Detection of enterovirus D68 in Canadian laboratories.Epidemiology of Enterovirus D68 in Ontario.Acute Respiratory Infections in Travelers Returning from MERS-CoV-Affected Areas.Genetic diversity and evolutionary insights of respiratory syncytial virus A ON1 genotype: global and local transmission dynamicsRecovery of influenza B virus with the H273Y point mutation in the neuraminidase active site from a human patient.Maternal vitamin D supplementation during pregnancy and lactation to prevent acute respiratory infections in infancy in Dhaka, Bangladesh (MDARI trial): protocol for a prospective cohort study nested within a randomized controlled trial.
P50
Q24273376-09CFA3B8-0C2A-4EA3-ABE3-7F657931B68DQ28730883-3EF0BD4D-40E0-4F1F-8DE1-84FB631CD5C2Q28741451-F335D3E1-492F-45A8-B345-E254258B62AEQ28742312-7911CC60-8C22-4220-BF51-9E20DAA6EB60Q28742786-FCD66618-3EE9-44F1-AF1D-1A3D77287B18Q28950446-29042FB3-5BFE-4F2B-998C-CD2F9CCD9863Q30145542-C46EEBE7-1D4C-426C-8E06-C93E2DE61B14Q30151372-DE455387-C152-46F1-96F6-CD2E0450BCD2Q30357871-4A67C123-178D-4F92-AF92-47EBA5FE76FBQ30359962-430EC91B-1713-4EFF-A89F-E505045E0297Q30377950-9FDA9087-2EF5-448F-A1B6-1D7D48C25E49Q30383197-13CF9871-458A-4910-84FB-ED6AFF429D87Q30395486-EA16E635-627E-43B2-AB9C-A96D172C3115Q30397613-81D1FD44-BC8E-4800-9784-2FBEB64BAA4AQ30397755-47C98957-4A3B-4DFE-982C-F792B31A2554Q30398770-7ECE85BB-7EB7-452A-AA69-4D2005AB3B8CQ30399334-377F754D-97B0-417B-A34D-4106A15FECCAQ30405331-5C17D7B6-A258-418A-A09A-B68B855904C5Q30405407-F21574F5-DD86-4E3A-91A1-254EE0BE740AQ30413349-7DCF4B15-0E1B-4ACF-B4F3-71782B21614CQ30420233-9D8BF9D8-B4CE-494E-AE93-BBF8325E2F1FQ30423221-DD9553E8-7C26-46D1-943A-B9BC349EF79AQ30424791-94BE2BBF-6597-48AE-9DE2-CC816201C78FQ30429951-F17629D5-6298-4833-8FC1-CCCDE2CA28ABQ30430123-64137DD0-7E2B-4B9F-820A-57F9F0B64341Q33713198-BC64EF89-AB2A-4409-9C26-E9F390176D35Q33908021-FE98CF10-F8BD-4B1F-B5A5-E681E402B814Q34292712-F18A1168-8C10-4BDE-89E4-E25203C5488AQ34597785-B0F0909F-39E0-4272-AC53-24B1D2153FFEQ34636807-D45795AE-E778-47E7-BE0A-AB98F0FAE05EQ35036264-FBA1AC07-8FE0-458D-B41F-8B753ADAB641Q35044990-200A708C-6C3A-44DC-9F84-3094B4E3D93BQ35130915-B14FADD3-CDD0-4BFD-AED5-E731051BE17CQ35192269-D20D2038-99E2-4C7D-B531-7F1710BD240CQ35455154-2C26F7D6-D944-46B1-BD05-B45850D42CC0Q35850006-4F41C035-9ABF-4620-9071-D4015E742CDBQ35997553-99DD71A3-BB4C-42A7-98F0-E4116B6FA8EAQ36106525-0B3227A9-DC88-41C1-9525-7A035D223C37Q36118639-78FB38DA-E821-4215-9718-ACCE7D1B3259Q36163106-424D2341-B29E-44DD-A7B7-CCD87A6BD3FC
P50
description
researcher
@en
wetenschapper
@nl
name
Jonathan B Gubbay
@en
Jonathan B Gubbay
@nl
type
label
Jonathan B Gubbay
@en
Jonathan B Gubbay
@nl
prefLabel
Jonathan B Gubbay
@en
Jonathan B Gubbay
@nl
P1960
rC0jh0gAAAAJ
P2038
Jonathan_Gubbay
P2798
P31
P496
0000-0003-0026-3786